These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17541984)

  • 1. Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine.
    Chagnon YC; Bureau A; Gendron D; Bouchard RH; Mérette C; Roy MA; Maziade M
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1063-9. PubMed ID: 17541984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses.
    Chagnon YC; Mérette C; Bouchard RH; Emond C; Roy MA; Maziade M
    Mol Psychiatry; 2004 Dec; 9(12):1067-74. PubMed ID: 15224101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-induced changes in glucose metabolism are independent of the melanin-concentrating hormone system.
    Girault EM; Toonen PW; Eggels L; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
    Psychoneuroendocrinology; 2013 Nov; 38(11):2640-6. PubMed ID: 23856185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.
    Ellingrod VL; Bishop JR; Moline J; Lin YC; Miller DD
    Psychopharmacol Bull; 2007; 40(1):57-62. PubMed ID: 17285096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
    Bonaccorso S; Sodhi M; Li J; Bobo WV; Chen Y; Tumuklu M; Theleritis C; Jayathilake K; Meltzer HY
    Bipolar Disord; 2015 Aug; 17(5):528-35. PubMed ID: 25874530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.
    Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S
    J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
    Newcomer JW; Campos JA; Marcus RN; Breder C; Berman RM; Kerselaers W; L'italien GJ; Nys M; Carson WH; McQuade RD
    J Clin Psychiatry; 2008 Jul; 69(7):1046-56. PubMed ID: 18605811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.
    Kang SG; Lee HJ; Park YM; Choi JE; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):160-3. PubMed ID: 17804136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.
    Fraguas D; Merchán-Naranjo J; Laita P; Parellada M; Moreno D; Ruiz-Sancho A; Cifuentes A; Giráldez M; Arango C
    J Clin Psychiatry; 2008 Jul; 69(7):1166-75. PubMed ID: 18588363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.
    Gagliano SA; Tiwari AK; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Knight J; Müller DJ
    Hum Psychopharmacol; 2014 Jul; 29(4):330-5. PubMed ID: 24737441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
    Moons T; Claes S; Martens GJ; Peuskens J; Van Loo KM; Van Schijndel JE; De Hert M; van Winkel R
    Schizophr Res; 2011 Feb; 125(2-3):187-93. PubMed ID: 21050724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Egberts AC; Scheffer H
    Pharmacogenomics J; 2007 Oct; 7(5):318-24. PubMed ID: 17016522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.
    Tiwari AK; Brandl EJ; Weber C; Likhodi O; Zai CC; Hahn MK; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):11-7. PubMed ID: 23277265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    J Clin Psychiatry; 2007 Nov; 68(11):1793-8. PubMed ID: 18052574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder.
    Lipkovich I; Jacobson JG; Hardy TA; Hoffmann VP
    BMC Psychiatry; 2008 Sep; 8():78. PubMed ID: 18793440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.
    Yang Y; Li W; Zhao J; Zhang H; Song X; Xiao B; Yang G; Jiang C; Zhang D; Yue W; Lv L
    Behav Brain Funct; 2012 Feb; 8():11. PubMed ID: 22369141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
    Henderson DC; Copeland PM; Daley TB; Borba CP; Cather C; Nguyen DD; Louie PM; Evins AE; Freudenreich O; Hayden D; Goff DC
    Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.
    Park YM; Cho JH; Kang SG; Choi JE; Lee SH; Kim L; Lee HJ
    J Clin Pharm Ther; 2008 Feb; 33(1):55-60. PubMed ID: 18211617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.